FindTrial
Sign In

Research on the application of immune training agents ß-glucan in patients with sepsis

Research on the application of immune training agents ß-glucan in patients with sepsis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080866
Enrollment
Unknown
Registered
2024-02-09
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Intervention Group:For the experimental group, at a dose of 40mg/kg/d, oral/nasogastric ß-glucan was administered twice a day for 14 days
control group:The control group received an oral placebo with the same ingredients except for ß-glucan twice a day for 14 days.

Sponsors

Longgang Central Hospital of Shenzhen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Those who meet the diagnostic criteria for sepsis; (2) Age = 18 years old

Exclusion criteria

Exclusion criteria: Brain-dead individuals; Patients or family members refuse to participate.

Design outcomes

Primary

MeasureTime frame
leukocyte count;Absolute value of lymphocytes; absolute value of neutrophil cell ;Lymphocyte ratio;Neutrophil ratio;platelet count;D-Dimer;ferritin;C-reactive protein;IL-6;CD14;CD45;HLA-DR;NLR;LCR;LeCR;LeIR;—

Secondary

MeasureTime frame
ICU mortality rate;ICU length of stay;—

Countries

China

Contacts

Public ContactWu Xiaoheng

Longgang Central Hospital of Shenzhen

yanluo@126.com+86 188 2384 0731

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026